259
Views
0
CrossRef citations to date
0
Altmetric
Review

Advances in Mechanistic Understanding of Release Rate Control Mechanisms of extended-release Hydrophilic Matrix Tablets

, , , , &
Pages 553-572 | Received 15 Apr 2016, Accepted 10 Jun 2016, Published online: 22 Jul 2016

References

  • Timmins P Brown J Meanwell N Hanna G Zhu L Kadow J . Enabled clinical utility of an HIV-1 attachment inhibitor through drug delivery. Drug Discov. Today19, 1288–1293 (2014).
  • Nicholson SJ Timmins P Dockens R et al. Development of oral extended-release formulations of 6-hydroxybuspirone. Biopharm. Drug Dispos.33, 522–535 (2012).
  • Good DJ Hartley R Mathias N et al. Mitigation of adverse clinical events of a narrow therapeutic index compound through modified release formulation design: an in vitro, in vivo, in silico, and clinical pharmacokinetic analysis. Mol. Pharm.12, 4434–4444 (2015).
  • Thombre AG . Extemporaneously prepared controlled release formulations for accelerating the early phase development of drug candidates. Drug Discov. Today19, 694–700 (2014).
  • Christensen GL Dale LB . Sustained release tablet. US patent US3065143 (1962).
  • Huber HE Dale LB Christensen GL . Utilization of hydrophilic gums for the control of drug release from tablet formulations. I. Disintegration and dissolution behavior. J. Pharm. Sci.55, 974–976 (1966).
  • Lapidus H Lordi NG . Some factors affecting the release of a water-soluble drug from a compressed hydrophilic matrix. J. Pharm. Sci.55, 840–843 (1966).
  • Winkle H . Implementing Quality by Design. Presented at : PDA/FDA joint regulatory conference. Washington, DC, USA, 24–28 September (2007).
  • US FDA . Guidance for Industry. Q8 (R2) Pharmaceutical Development. Department of Health and Human Services, Silver Spring, MD USA (2008).
  • Singh SK Venkateshwarn TG Simmons SP . Oral Controlled drug delivery: quality by design (QbD) approach to drug development. In : Oral Controlled Release Formulation Design And Drug Delivery: Theory To Practice. WenHParkK ( Eds). John Wiley, Hoboken, NJ, USA (2010).
  • Alderman DA . A review of cellulose ethers in hydrophilic matrices for oral controlled release dosage forms. Int. J. Pharm. Tech. Prod. Manuf.5, 1–9 (1984).
  • Hogan JE . Hydroxypropylmethylcellulose sustained release technology. Drug Dev. Ind. Pharm.15, 975–999 (1989).
  • Melia CD . Hydrophilic matrix sustained release systems based on polysaccharide carriers. Crit. Rev. Ther Drug.8, 395–421 (1991).
  • Colombo P . Swelling-controlled release in hydrogel matrices for oral use. Adv. Drug Del. Rev.11, 37–57 (1993).
  • Li CL Martini LG Ford JL Roberts M . The use of hypromellose in oral drug delivery. J. Pharm. Pharmacol.57, 533–546 (2005).
  • Wen X Nokhodchi A Rajabi-Siaboomi A . Oral extended-release hydrophilic matrices: formulation and design. In : Oral Controlled Release Formulation Design and Drug Delivery: Theory To Practice. WenHParkK ( Eds). Wiley, Hoboken, NJ, USA (2010).
  • Maderuelo C Zarzuelo A Lanao JM . Critical factors in the release of drugs from sustained release hydrophilic matrices. J. Control. Rel.154, 2–19 (2011).
  • Timmins P Melia CD Pygall SR . Hydrophilic Matrix Tablets for Oral Controlled Release. AAPS Press/Springer, NY, USA (2014).
  • Reynolds TD Mitchell SA Balwinski KM . Investigation of the effect of tablet surface area/volume ratio on drug release from hydroxypropylmethylcellulose controlled-release matrix tablets. Drug Dev. Ind. Pharm.29, 457–466 (2002).
  • Cobby J Mayersohn M Walker GC . Influence of shape factors on the kinetics of drug release from matrix tablets I: theoretical. J. Pharm. Sci.63, 725–732 (1974).
  • Cobby J Mayersohn M Walker GC . Influence of shape factors on the kinetics of drug release from matrix tablets II: experimental. J. Pharm. Sci.63, 732–737 (1974).
  • Siepmann J Kranz H Peppas NA Bodmeier R . Calculation of the required size and shape of hydroxypropyl methylcellulose matrices to achieve desired drug release profiles. Int. J. Pharm.201, 151–164 (2000).
  • Parojčič J Đurič Z Jovanovič M Ibrič S . An investigation into the factors influencing drug release from hydrophilic matrix tablets based on novel carbomer polymers. Drug Deliv.11, 55–65 (2004).
  • Mitchell K Ford JL Armstrong DJ Elliott PNC Rostron C Hogan JE . The influence of concentration on the release of drugs from gels and matrices containing Methocel®. Int. J. Pharm.100, 155–163 (1993).
  • Velasco MV Ford JL Rowe P Rajabi-Siaboomi AR . Influence of drug: hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. J. Control. Rel.57, 75–85 (1999).
  • Varma MV Kaushal AM Garg A Garg S . Factors affecting mechanism and kinetics of drug release from matrix-based oral controlled drug delivery systems. Am. J. Drug Deliv.2, 43–57 (2004).
  • Colombo P Bettini R Santi P Peppas NA . Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. Pharm. Sci. Tech. Today3, 198–204 (2000).
  • Colombo P Bettini R Santi P De Ascentis A Peppas N . Analysis of the swelling and release mechanisms from drug delivery systems with emphasis on drug solubility and water transport. J. Control. Rel.39, 231–237 (1996).
  • Roy DS Rohera BD . Comparative evaluation of rate of hydration and matrix erosion of HEC and HPC and study of drug release from their matrices. Eur. J. Pharm. Sci.16, 193–199 (2002).
  • Franek F Holm P Larsenc F Steffansen B . Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: Comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3. Int. J. Pharm.461, 419–426 (2014).
  • Ebube NK Hika AH Wyandt CM Beer DC Miller LG Jones AB . Sustained release of acetaminophen from heterogeneous matrix tablets: influence of polymer ratio, polymer loading, and co-active on drug release. Pharm. Dev. Tech.2, 161–170 (1997).
  • Chaibva FA Khamanga SM Walker RB . Swelling, erosion and drug release characteristics of salbutamol sulfate from hydroxypropyl methylcellulose-based matrix tablets. Drug Dev. Ind. Pharm.36, 1497–1510 (2010).
  • Khamanga SM Walker RB . Evaluation of rate of swelling and erosion of verapamil (VRP) sustained-release matrix tablets. Drug Dev. Ind. Pharm.32, 1139–1148 (2006).
  • Ranga Rao KV Padmalatha Devi K Buri P . Cellulose matrices for zero-order release of soluble drugs. Drug Dev. Ind. Pharm.14, 2299–2320 (1988).
  • Ghimire M Hodges LA Band J et al. In vitro and in vivo erosion profiles of hydroxypropylmethylcellulose (HPMC) matrix tablets. J. Control. Rel.147, 70–75 (2010).
  • Timmins P Delargy AM Howard JR . Optimization and characterization of a pH independent extended-release hydrophilic matrix tablet. Pharm. Dev. Technol.2, 25–31 (1997).
  • Hanley S Brown J Timmins P . Investigation into the potential for prodrug hydrolysis within a hydrated HPMC matrix. Presented at : APS PharmSci meeting. Edinburgh, UK (2013).
  • Jain AK Sönderlind E Viridén A et al. The influence of hydroxypropylmethylcellulose (HPMC) molecular weight, concentration and effect of food on in vivo erosion behavior of HPMC matrix tablets. J. Control. Rel.87, 50–58 (2014).
  • Ghori MU Ginting G Smith AM Conway BR . Simultaneous quantification of drug release and erosion from hypromellose hydrophilic matrices. Int. J. Pharm.465, 405–412 (2014).
  • Shameem M Katori N Aoyagi N Kojima S . Oral solid controlled release dosage forms: role of GI-mechanical destructive forces and colonic release in drug absorption under fasted and fed conditions in humans. Pharm. Res.12, 1049–1054 (1995).
  • Davis J Burton J Connor AL Macrae R Wilding IR . Scintigraphic study to investigate the effect of food on an HPMC modified release formulation of UK-294,315. J. Pharm. Sci.98, 1568–1576 (2009).
  • Abrahamsson B Pal A Sjöberg M Carlsson M Laurell E Brasseur JG . A novel in vitro and numerical analysis of shear-induced drug release form extended-release tablets in the fed stomach. Pharm. Res.22, 1215–1226 (2005).
  • Kozoliek M Görke K Neumann M Garbacz G Weitschies W . Development of a bio-relevant dissolution test device simulating mechanical aspects present in the fed stomach. Eur. J. Pharm. Sci.57, 250–256 (2014).
  • Klančar U Horvat M Baumgartner S . Correlating cellulose derivative intrinsic viscosity with mechanical susceptibility of swollen hydrophilic matrix tablet. AAPS PharmSciTech13, 903–91 (2012).
  • Takieddin M Fassihi R . A novel approach in distinguishing between role of hydrodynamics and mechanical stresses similar to contraction forces of GI tract on drug release from modified release dosage forms. AAPS PharmSciTech16, 278–283 (2015).
  • Klančar U Markum B Baumgartner S Legen I . A novel beads-based dissolution method for the in vitro evaluation of extended-release HPMC matrix tablets and he correlation with the in vivo data. AAPS J.15, 267–277 (2013).
  • Leuenberger H Rohera BD Hass C . Percolation theory–a novel approach to solid dosage form design. Int. J. Pharm.90, 213–219 (1987).
  • Leuenberger H . The application of percolation theory in powder technology. Adv. Powder Technol.10, 323–352 (1999).
  • Bonny JD Leuenberger H . Matrix type controlled release systems: I. Effect of percolation on drug dissolution kinetics. Pharm. Acta Helv.66, 160–164 (1991).
  • Caraballo I . Factors affecting drug release from hydroxypropyl methylcellulose matrix systems in the light of classical and percolation theories. Expert Opin. Drug Deliv.7, 1291–1301 (2010).
  • Miranda A Millán M Caraballo I . Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery. Int. J. Pharm.311, 75–81 (2006).
  • Fuertes I Miranda A Millán M Caraballo I . Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets. Eur J. Pharm. Biopharm.64, 336–342 (2006).
  • Gonçalves-Araújo T Rajabi-Siahboomi AR Caraballo I . Application of percolation theory in the study of an extended-release verapamil hydrochloride formulation. Int. J. Pharm.361, 112–117 (2008).
  • Gil EC Colarte AI Bataille B Brouillet F Caraballo I . Estimation of the percolation thresholds in ternary lobenzarit disodium-dextran-HPMC hydrophilic matrices tablets: effects of initial porosity. Eur. J. Pharm. Sci.38, 312–319 (2009).
  • Gonçalves-Araújo T Rajabi-Siahboomi AR Caraballo I . Polymer percolation threshold on HPMC extended-release formulation of carbamazepine and verapamil HCl. AAPS PharmSciTech11, 558–562 (2010).
  • Fuertes I Caraballo I Miranda A Millán M . Study of critical points of drugs with different solubilities in hydrophilic matrices. Int. J. Pharm.383, 138–146 (2010).
  • Aguilar-de-Leyva A Cifuentes C Rajabi-Siahboomi AR Caraballo I . Study of the critical points and the role of the pores and viscosity in carbamazepine hydrophilic matrix tablets. Eur J. Pharm. Biopharm.80, 136–142 (2012).
  • Mitchell K Ford JL Armstrong DJ Elliott PNC Hogan JE Rostron C . The influence of the particle size of hydroxypropylmethylcellulose K15M on its hydration and performance in matrix tablets. Int. J. Pharm.100, 175–179 (1993).
  • Ford JL Rubinstein MF Hogan JE . Formulation of sustained release promethazine hydrochloride tablets using hydroxypropyl methylcellulose matrices. Int. J. Pharm.24, 327–338 (1985).
  • Ford JL Rubinstein MF Hogan JE . Propranolol hydrochloride and aminophylline release from matrix tablets containing hydroxypropylmethylcellulose. Int. J. Pharm.24, 339–350 (1985).
  • Heng PWS Chan LW Easterbrook MG Li X . Investigation of the influence of mean HPMC particle size and number of polymer particles on the release of aspirin from swellable hydrophilic matrix tablets. J. Control. Release76, 39–49 (2001).
  • Mitchell SA Balwinski KM . Investigation of hypromellose particle size effects on drug release from sustained release hydrophilic matrix tablets. Drug Dev. Ind. Pharm.33, 952–958 (2007).
  • Shaojee S Emami P Mahmood A et al. An investigation on the effect of polyethylene oxide concentration and particle size in modulating theophylline release from tablet matrices. AAPS PharmSciTech16, 1281–1289 (2015).
  • Velasco MV Ford JL Rowe P Rajabi-Siahboomi AR . Influence of drug:hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. J. Control. Rel.57, 75–85 (1999).
  • Miranda A Millán M Caraballo I . Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets. J. Pharm. Sci.96, 2746–2756 (2007).
  • Mitchell K Ford JL Armstrong DJ Elliott PNC Hogan JE Rostron C . The influence of substitution type on the performance of methylcellulose and hydroxypropyl methylcellulose in gels and matrices. Int. J. Pharm.100, 143–154 (1993).
  • Ford JL Rubinstein MF McCaul F Hogan JE Edgar PJ . Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropylmethylcelluslose matrix tablets. Int. J. Pharm.40, 223–234 (1987).
  • Campos-Aldrete ME Villafuerte-Robles L . Influence of the viscosity grade and particle size of HPMC on metronidazole release from matrix tablets. Int. J. Pharm.43, 173–178 (1997).
  • Tiwari SB Murthy TK Pai MP Mehta PR Chowary PB . Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system. AAPS PharmSciTech4, 18–23 (2003).
  • Ebube NK Jones AB . Sustained release of acetaminophen form a heterogenous mixture of two hydrophilic non-ionic cellulose ether polymers. Int. J. Pharm.272, 19–27 (2004).
  • Bajwa GS Hoebler K Sammon C Timmins P Melia CD . Microstructural imaging of early gel layer formation in HPMC matrices. J. Pharm. Sci.95, 2145–2157 (2006).
  • Pygall SR Kujawinski S Timmins P Melia CD . Mechanisms of drug release in citrate buffered HPMC matrices. Int. J. Pharm.370, 110–120 (2009).
  • Williams HD Ward R Hardy IJ Melia CD . The effect of sucrose and salts in combination on the drug release behaviour of an HPMC matrix. Eur. J. Pharm. Biopharm.76, 443–436 (2010).
  • Williams HD Ward R Hardy IJ Melia CD . The extended-release properties of HPMC matrices in the presence of dietary sugars. J. Control. Rel.138, 251–259 (2009).
  • Mason LM Campiñez MD Pygall SR et al. The influence of polymer content on early gel-layer formation in HPMC matrices: the use of CLSM visualization to identify the percolation threshold. Eur. J. Pharm. Biopharm.94, 485–492 (2015).
  • Lapidus H Lordi NG . Drug release from compressed hydrophilic matrices. J. Pharm. Sci.57, 1292–1301 (1968).
  • Gao P Nixon PR Skoug JW . Diffusion in HPMC gels. II: prediction of drug release rates form hydrophilic matrix extended-release dosage forms. Pharm. Res.12, 965–971 (1995).
  • Siepmann J Kranz H Bodmeier R Peppas NA . HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling and dissolution mechanisms for predicting the release kinetics. Pharm. Res.16, 1748–1756 (1999).
  • Richardson JC Bowtell RW Mäder K Melia CD . Pharmaceutical applications of magnetic resonance imaging. Adv. Drug Deliv. Rev.57, 1191–1209 (2005).
  • Nott KP . Magnetic resonance imaging of tablet dissolution. Eur. J. Pharm. Biopharm.74, 78–83 (2010).
  • Mikac U Kristl J Baumgartner S . Using quantitative magnetic resonance methods to understand better the gel-layer formation on polymer-matrix tablets. Expert Opin. Drug Deliv.8, 677–692 (2011).
  • Melia CD Rajabi-Siahboomi AR Bowtell RW . Magnetic resonance imaging of controlled release pharmaceutical dosage forms. Pharm. Sci. Tech Today.1, 32–39 (1998).
  • Fyfe CA Blazek-Welsh AI . Quantitative NMR imaging study of the mechanism of drug release from swelling hydroxypropylmethylcellulose tablets. J. Control. Rel.68, 313–333 (2000).
  • Narasimhan B Snaar JEM Bowtell RW Morgan S Melia CD Peppas NA . Magnetic resonance imaging analysis of molecular mobility during dissolution of poly(vinyl alcohol) in water. Macromolecules32, 704–710 (1999).
  • Rajabi-Siahboomi AR Bowtell RW Mansfield P Henderson A Davies MC Melia CD . Structure and behaviour in hydrophilic matrix sustained release dosage forms: 2 NMR imaging studies of dimensional changes in the gel layer and core of HPMC tablets undergoing hydration. J. Control. Rel.31, 121–128 (1994).
  • Tritt-Goc J Piślewski N . Magnetic resonance imaging study of the swelling kinetics of hydroxpropylmethylcellulose (HPMC) in water. J. Control. Release80, 79–86 (2002).
  • Chen YY Hughes LP Gladden LF Mantle MD . Quantitative ultra-fast MRI of HPMC swelling and dissolution. J. Pharm. Sci.99, 3462–3472 (2010).
  • Metz H Mäder K . Benchtop-NMR and MRI–a new analytical tool in drug delivery research. Int. J. Pharm.364, 170–175 (2008).
  • Hills BP . Applications of low-field NMR to food science. Annu. Rep. NMR. Spectrosc.58, 177–230 (2006).
  • Timmins P Hanley S Brown J . Mechanistic insights of the effect of process and formulation variables on the performance of hydrophilic matrix tablets using magnetic resonance imaging. Presented at : 40th Annual Meeting And Exposition On The Controlled Release Society. Honolulu, Hawaii (2013).
  • Williams HD Nott KP Barrett DA Ward R Hardy IJ Melia CD . Drug release from HPMC matrices in milk and fat-rich emulsions. J. Pharm. Sci.100, 4823–4835 (2011).
  • Kazarian SG Chan KLA . ‘Chemical photography’ of drug release. Macromolecules36, 9866–9872 (2003).
  • Bobiak JP Koenig JL . Regions of interest in FTIR imaging applications: diffusion of nicotine into ethylene-co-vinyl acetate films. J. Control. Rel.106, 329–338 (2005).
  • Coutts-Lendon CA Wright NA Mieso EV Koenig JL . The use of FT-IR imaging as an analytical tool for the characterization of drug delivery systems. J. Control. Rel.93, 223–248 (2003).
  • Chan KLA Hammond SV Kazarian SG . Applications of attenuated total reflection infrared spectroscopic imaging to pharmaceutical formulations. Anal. Chem.75, 2140–2146 (2003).
  • van der Weerd J Chan KLA Kazarian SG . An innovative design of compaction cell for in situ FT-IR imaging of tablet dissolution. Vib. Spectrosc.35, 9–13 (2004).
  • van der Weerd J Kazarian SG . Combined approach of FTIR imaging and conventional dissolution tests applied to drug release. J. Control. Rel.98, 295–305 (2004).
  • van der Weerd J Kazarian SG . Validation of macroscopic ATR-FTIR imaging to study dissolution of swelling pharmaceutical tablets. Appl. Spectrosc.58, 1413–1419 (2004).
  • Gao P Skoug JW Nixon PR Ju TR Stemm NL Sung K . Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release. J. Pharm. Sci.85, 732–740 (1996).
  • Bettini R Cattelani PL Santi P Massimo G Peppas NA Colombo P . Translocation of drug particles in HPMC matrix gel layer, effect of drug solubility and influence on release rate. J. Control. Rel.70, 383–391 (2001).
  • Kazarian SG van der Weerd J . Simultaneous FTIR spectroscopic imaging and visible photography to monitor tablet dissolution and drug release. Pharm. Res.25, 853–860 (2008).
  • Gao P Meury RH . Swelling of hydroxypropyl methylcellulose matrix tablets. 1. Characterization of swelling using a novel optical imaging method. J. Pharm. Sci.85, 725–731 (1996).
  • Melia CD Rajabi-Siahboomi AR Davies MC . The development of structural features in the surface gel layer of hydrating HPMC hydrophilic matrices. Proceed. Intern. Symp. Control. Rel. Bioact. Mater.19, 28–29 (1992).
  • Wray PS Clarke GS Kazarian SG . Application of FTIR spectroscopic imaging to study the effects of modifying the pH microenvironment on the dissolution of ibuprofen from HPMC matrices. J. Pharm. Sci.100, 4745–4755 (2011).
  • Pudla M Kyeremateng SO Williams LAM Kimber JA van Lishaut H Kazarian SG . Analyzing the impact of different excipients on drug release behavior in hot-melt extrusion formulations using FTIR spectroscopic imaging. Eur. J. Pharm. Sci.67, 21–31 (2015).
  • Mitchell K Ford JL Armstrong DJ Elliott PNC Rostron C Hogan JE . The influence of additives on the cloud point, disintegration and dissolution of hydroxypropylmethylcellulose gels and matrix tablets. Int. J. Pharm.66, 233–242 (1990).
  • Velasco D Danou CB Renonondo JA et al. pH sensitive polymer hydrogels derived from morpholine avoid the crystallization of ibuprofen. J. Control. Rel.149, 140–145 (2011).
  • Colombo P Conte U Gazzaniga A et al. Drug release modulation by physical restrictions of matrix swelling. Int. J. Pharm.63, 43–48 (1990).
  • Wray PS Li J Li LQ Kazarian SG . Combined study of biphasic and zero-order release formulations with dissolution tests and ATR-FTIR spectroscopic imaging. J. Pharm. Sci.103, 1995–2004 (2014).
  • Peppas NA Sahlin JJ . A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int. J. Pharm.57, 169–172 (1989).
  • Wray PS Clarke GS Kazarian SG . Dissolution of tablet-in-tablet formulations studied with ATR-FTIR spectroscopic imaging. Eur. J. Pharm. Sci.48, 748–757 (2013).
  • Kimber JA Kazarian SG Štěpánek F . Microstructure-based mathematical modelling and spectroscopic imaging of tablet dissolution. Comput. Chem. Eng.35, 1328–1339 (2011).
  • Kimber JA Kazarian SG Štěpánek F . Modelling of pharmaceutical tablet swelling and dissolution using discrete element method. Chem. Eng. Sci.69, 394–403 (2012).
  • Hardy IJ Windberg-Baarup A Neri C Byway PV Booth SW Fitzpatrick S . Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone. Int. J. Pharm.337, 246–253 (2007).
  • Li W Woldu A Araba L Winstead D . Determination of water penetration and drug concentration profiles in HPMC-based matrix tablets by near infrared chemical imaging. J. Pharm. Sci.99, 3081–3088 (2010).
  • Avalle P Pygall SR Gower N Midwinter A . The use of in situ near infrared spectroscopy to provide mechanistic insights into gel layer development in HPMC hydrophilic matrices. Eur. J. Pharm. Sci.43, 400–408 (2011).
  • Avalle P Pygall SR Pritchard J Jastrzemska A . Interrogating erosion-based drug liberation phenomena from hydrophilic matrices using near infrared (NIR) spectroscopy. Eur. J. Pharm. Sci.48, 72–79 (2013).
  • Ishikawa D Murayama K Genkawa T Awa K Komiyama M Ozaki Y . Development of a compact near infrared imaging device with high-speed and portability for pharmaceutical process monitoring. NIR News23, 14–17 (2012).
  • Ishikawa D Murayama K Awa K et al. Application of a newly developed portable NIR imaging device to monitor the dissolution process of tablets. Anal. Bioanal. Chem.405, 9401–9409 (2013).
  • Choi DH Kim KH Park JS Jeong SH Park K . Evaluation of drug delivery profiles in geometric three-layered tablets with various mechanical properties, in vitro in vivo drug release, and Raman imaging. J. Control. Rel.172, 763–772 (2013).
  • Yassin S Su K Lin H Gladden LF Zeitler JA . Diffusion and swelling measurements in pharmaceutical powder compacts using terahertz pulsed imaging. J. Pharm. Sci.104, 1658–1667 (2015).
  • Ye F Yaghmur A Jensen H Larsen SW Larsen C Østergaard J . Real-time UV imaging of drug diffusion and release from Pluronic F127 hydrogels. Eur. J. Pharm. Sci.43, 236–243 (2011).
  • Boetker JP Savolainen M Koradia V et al. insights into the early dissolution events of amlodipine using UV imaging and raman spectroscopy. Mol. Pharm.8, 1372–1380 (2011).
  • Pajander J Baldursdottir S Rantanen J Østergaard J . Behaviour of HPMC compacts investigated using UV-imaging. Int. J. Pharm.427, 345–353 (2012).
  • Sieppman J Siepmann F . Mathematical modeling of drug dissolution. Int. J. Pharm.453, 12–24 (2013).
  • Higuchi T . Rate of release of medicaments from ointment bases containing drugs in suspension. J. Pharm Sci.50, 874–875 (1961).
  • Higuchi WI . Analysis of data on the medicament release from ointments. J. Pharm. Sci.50, 802–804 (1962).
  • Hixson AW Crowell JH . Dependence of reaction velocity on surface and agitation. Ind. Eng. Chem.23, 802–804 (1931).
  • Langenbucher F . Linearization of dissolution curve rates by the Weibull distribution. J. Pharm. Pharmacol.24, 979–981 (1972).
  • Papadopoulou V Kosmidis K Vlachou M Macheras P . On the use of the Weibull function for the discernment of drug release mechanisms. Int. J. Pharm.309, 44–50 (2006).
  • Gomez-Mantilla JD Schafer UF Casabo VG Lehr T Lehr CM . Statistical comparison of dissolution profiles to predict the bioequivalence of extended-release formulations. AAPS J.16, 791–801 (2014).
  • Sieppman J Peppas NA . Modeling of drug release from delivery systems based on hydroxypropylmethylcellulose. Adv. Drug Deliv. Rev.64, 163–74 (2012).
  • Korsmeyer RW Gurny R Doelker E Buri P Peppas NA . Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm.15, 25–35 (1983).
  • Colombo P Bettini R Massimo G Catellani P Santi P Peppas NA . Drug diffusion front movement is important in drug release control from swellable matrix tablets. J. Pharm. Sci.84, 991–997 (1995).
  • Ferrero C Munoz-Ruiz A Jimenez-Castellanos MR . Fronts movement as a useful tool for hydrophilic matrix release elucidation mechanism. Int. J. Pharm.202, 21–28 (2000).
  • Kill S Dam-Johansen K . Controlled drug delivery from swellable hydroxypropylmethylcellulose matrices, model-based analysis of observed radial from movements. J. Control. Rel.107, 320–329 (2003).
  • Frenning G Brohede U Stromme M . Finite element analysis of the release of slowly dissolving drugs from cylindrical matrix systems. J. Control. Rel.107, 320–329 (2005).
  • Lamberti G Galdi I Barba AA . Controlled release from hydrogel-based solid matrices. A model accounting for water uptake, swelling and erosion. Int. J. Pharm.407, 78–86 (2011).
  • Galdi I Lamberti G . Drug release from matrix systems, analysis by finite element methods. Heat Mass Transf.48, 519–528 (2011).
  • Siepmann J Karout Y Gehrke M Penz FK Siepmann F . Predicting drug release from HPMC/lactose tablets. Int. J. Pharm.441, 826–834 (2013).
  • Xu Y Jia Y Wang Z Wang Z . Mathematical modeling and finite element simulation of slow release of drugs using hydrogels as carriers with various concentration distributions. J. Pharm. Sci.102, 1532–1543 (2013).
  • Saleshi A Zhao J Cabelka T Larson R . A unified multicomponent stress-diffusion model of drug release from non-biodegradable polymeric matrix tablets. J. Control. Rel.224, 43–58 (2016).
  • Chen W Desai D Good D et al. Mathematical model-based accelerated development of extended-release metformin hydrochloride tablet formulation. AAPS PharmSciTech doi:10.1208/s12249-015-0423-9 (2015).
  • Timmins P Dennis AB Vyas KA . Biphasic controlled release delivery system for high solubility pharmaceuticals and method. US Patent US6475521 (2002).
  • Timmins P Donahue S Meeker J Marathe P . Steady state pharmacokinetics of a novel extended-release metformin formulation. Clin. Pharmacokinet.44, 721–729 (2005).
  • Brown J Crison J Timmins P . Predicting feasibility and characterizing performance of extended-release formulations using physiologically based pharmacokinetic modelling. Ther. Deliv.3, 1047–1059 (2012).
  • Brown J Chen C Zhu L et al. Compartmental absorption modelling and site of absorption studies to determine feasibility of an extended-release formulation of an HIV attachment inhibitor phosphate ester prodrug. J. Pharm. Sci.102, 1742–1751 (2013).
  • Kulinowski P Woya-Orlewicz K Rappen GM Haznar-Garbacz D Węglarz WP Dorożyński PP . An understanding of modiified release matrix tabets behavior during drug dissolution as the key for prediction of pharmacetical product performance–case study of a multimodal characterization of quetiapine fumarate tablets. Int. J. Pharm.484, 235–245 (2015).
  • McDermott J Scholes P Lin W Connor A . Approaches to rapid in vivo optimization of hydrophilic matrix tablets. In : Hydrophilic Matrix Tablets for Oral Controlled Release. TimminsPPygallSRMeliaCD ( Eds). Springer, NY, USA (2014).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.